Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

STAR study will compare raloxifene to tamoxifen for reducing risk of breast cancer

Oct. 26, 1998

Thalidomide designated orphan drug for multiple myeloma

Oct. 26, 1998

Camptosar receives final FDA approval for colorectal cancer

Oct. 26, 1998

Naamidine A identified as EGF receptor antagonist and antiproliferative agent

Oct. 26, 1998

Nonsteroid progesterone antagonists for cancer, gynecological disorders

Oct. 26, 1998

Beta-glucuronidase inhibitors as antitumor/antiinflammatory agents

Oct. 26, 1998

Potent antitumor activity, low toxicity observed in in vitro studies of aplidine

Oct. 23, 1998

Cell Therapeutics initiates phase I lisofylline trial for treatment of mucositis

Oct. 22, 1998

ODAC votes against Warner-Lambert's prostate cancer drug

Oct. 20, 1998

Paclitaxel derivatives useful as antitumor agents prepared at BMS

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...